Park National Corp Abbott Laboratories Transaction History

Park National Corp

  • $2.82 Billion
  • Q3 2024

A detailed history of Park National Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Park National Corp holds 271,711 shares of ABT stock, worth $30.8 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
271,711
Previous 277,720 2.16%
Holding current value
$30.8 Million
Previous $28.9 Million 7.35%
% of portfolio
1.1%
Previous 1.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024
SELL
$100.07 - $118.13 $601,320 - $709,843
-6,009 Reduced 2.16%
271,711 $31 Million
Q2 2024

Jul 15, 2024
SELL
$100.73 - $112.44 $3.53 Million - $3.94 Million
-35,018 Reduced 11.2%
277,720 $28.9 Million
Q1 2024

Apr 01, 2024
SELL
$109.52 - $120.96 $2.87 Million - $3.17 Million
-26,182 Reduced 7.73%
312,738 $35.5 Million
Q4 2023

Jan 02, 2024
SELL
$90.19 - $110.4 $2.86 Million - $3.5 Million
-31,690 Reduced 8.55%
338,920 $37.3 Million
Q3 2023

Oct 02, 2023
SELL
$95.53 - $114.62 $765,864 - $918,908
-8,017 Reduced 2.12%
370,610 $35.9 Million
Q2 2023

Jul 03, 2023
SELL
$100.78 - $112.29 $1.2 Million - $1.34 Million
-11,941 Reduced 3.06%
378,627 $41.3 Million
Q1 2023

Apr 03, 2023
SELL
$96.86 - $114.01 $924,625 - $1.09 Million
-9,546 Reduced 2.39%
390,568 $39.5 Million
Q4 2022

Feb 06, 2023
SELL
$95.06 - $111.52 $1.59 Million - $1.86 Million
-16,701 Reduced 4.01%
400,114 $43.9 Million
Q3 2022

Oct 03, 2022
BUY
$96.76 - $112.03 $3.63 Million - $4.2 Million
37,507 Added 9.89%
416,815 $40.3 Million
Q2 2022

Jul 01, 2022
SELL
$102.07 - $123.37 $275,793 - $333,345
-2,702 Reduced 0.71%
379,308 $41.2 Million
Q1 2022

Apr 01, 2022
SELL
$114.02 - $139.04 $315,037 - $384,167
-2,763 Reduced 0.72%
382,010 $45.2 Million
Q4 2021

Jan 04, 2022
SELL
$115.53 - $141.46 $3.47 Million - $4.25 Million
-30,070 Reduced 7.25%
384,773 $54.2 Million
Q3 2021

Oct 01, 2021
SELL
$116.66 - $129.06 $2.23 Million - $2.47 Million
-19,136 Reduced 4.41%
414,843 $49 Million
Q2 2021

Jul 01, 2021
SELL
$105.79 - $124.53 $1.92 Million - $2.26 Million
-18,178 Reduced 4.02%
433,979 $50.3 Million
Q1 2021

Apr 01, 2021
SELL
$108.84 - $128.23 $4.27 Million - $5.03 Million
-39,207 Reduced 7.98%
452,157 $54.2 Million
Q4 2020

Jan 04, 2021
SELL
$105.0 - $114.42 $920,955 - $1 Million
-8,771 Reduced 1.75%
491,364 $53.8 Million
Q3 2020

Oct 01, 2020
SELL
$91.64 - $111.29 $1.54 Million - $1.87 Million
-16,833 Reduced 3.26%
500,135 $54.4 Million
Q2 2020

Jul 01, 2020
SELL
$76.57 - $98.0 $1.22 Million - $1.56 Million
-15,966 Reduced 3.0%
516,968 $47.3 Million
Q1 2020

Apr 01, 2020
SELL
$62.82 - $91.86 $811,571 - $1.19 Million
-12,919 Reduced 2.37%
532,934 $42.1 Million
Q4 2019

Jan 02, 2020
BUY
$78.51 - $87.4 $247,227 - $275,222
3,149 Added 0.58%
545,853 $47.4 Million
Q3 2019

Oct 01, 2019
SELL
$81.84 - $88.74 $8,511 - $9,228
-104 Reduced 0.02%
542,704 $45.4 Million
Q2 2019

Jul 01, 2019
SELL
$72.88 - $85.0 $522,768 - $609,705
-7,173 Reduced 1.3%
542,808 $45.7 Million
Q1 2019

Apr 01, 2019
SELL
$66.22 - $80.06 $188,991 - $228,491
-2,854 Reduced 0.52%
549,981 $44 Million
Q4 2018

Jan 02, 2019
SELL
$65.56 - $74.27 $68,969 - $78,132
-1,052 Reduced 0.19%
552,835 $40 Million
Q3 2018

Oct 02, 2018
BUY
$60.81 - $73.36 $252,300 - $304,370
4,149 Added 0.75%
553,887 $40.6 Million
Q2 2018

Jul 02, 2018
SELL
$57.57 - $63.54 $326,249 - $360,081
-5,667 Reduced 1.02%
549,738 $33.5 Million
Q1 2018

Apr 02, 2018
SELL
$56.27 - $63.62 $1.54 Million - $1.74 Million
-27,404 Reduced 4.7%
555,405 $33.3 Million
Q4 2017

Jan 02, 2018
SELL
$53.68 - $57.47 $1.04 Million - $1.12 Million
-19,427 Reduced 3.23%
582,809 $33.3 Million
Q3 2017

Oct 02, 2017
BUY
$48.06 - $53.64 $28.9 Million - $32.3 Million
602,236
602,236 $32.1 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Park National Corp Portfolio

Follow Park National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Park National Corp , based on Form 13F filings with the SEC.

News

Stay updated on Park National Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email